Opendata, web and dolomites

OPVANOX-ARDS SIGNED

Advanced pulmonary vascular monitoring for optimum Nitric Oxide delivery in acute respiratory distress syndrome. Expanding Nitric Oxide applications

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 OPVANOX-ARDS project word cloud

Explore the words cloud of the OPVANOX-ARDS project. It provides you a very rough idea of what is the project "OPVANOX-ARDS" about.

clinically    algorithms    business    clinical    acquire    monitoring    lack    expanding    combine    variables    patient    respiratory    proven    of    skills    form    benefit    gas    vascular    expecting    emission    enterprise    guide    effect    performance    pulmonary    researcher    biologic    tools    therapies    imaging    waveform    worldwide    mechanics    inhaled    oriented    animal    distress    oxide    nitric    quantitative    ards    dysfunction    severe    physiology    acute    entails    administration    pressure    models    representative    expertise    safety    physiologic    tomography    delivering    efficient    positron    turning    algorithm    academy    mortality    incorporation    uncontrolled    companies    competitive    magnetic    involve    software    company    prognosis    industry    gain    monitors    bedside    dose    despite    edge    invasive    efficiency    artery    treatment    patients    resonance    minimum    outcomes    technologies    career    positioned    clear    improves    syndrome   

Project "OPVANOX-ARDS" data sheet

The following table provides information about the project.

Coordinator
INGENIERIA Y TECNICAS CLINICAS SA 

Organization address
address: CALLE TUNGSTENO 11-13
city: ARGANDA DEL REY - MADRID
postcode: 28500
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 158˙121 €
 EC max contribution 158˙121 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2020-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INGENIERIA Y TECNICAS CLINICAS SA ES (ARGANDA DEL REY - MADRID) coordinator 158˙121.00

Map

 Project objective

Acute respiratory distress syndrome (ARDS) is the most severe form of respiratory failure. Pulmonary vascular dysfunction during ARDS increases mortality and therapies focused in improving pulmonary vascular mechanics could improve patient prognosis. Inhaled Nitric Oxide (NO), improves pulmonary vascular mechanics, but despite of this effect, has not proven to improve outcomes in ARDS. One of the most representative problems is the lack of information of the quantitative dose used and all consequences that this uncontrolled administration entails. In this project we aim to establish bedside physiologic variables and algorithms to guide efficient NO delivery during ARDS. It will involve the collaboration between an enterprise that has developed a new NO delivering system and is looking for expanding its applications and a researcher with expertise in physiology, imaging and biologic variables monitoring. As a result of this collaboration, the company will gain a quantitative way of determining the treatment efficiency that could be used in this and other applications, a more patient-oriented and physiology-focused approach for this product and the researcher will acquire skills for turning his career from the academy to the industry side. This research will combine edge technology to define bedside tools for patients monitoring with the application of this information for improving the performance of the delivery system. Clinically relevant imaging tools such as Magnetic Resonance Imaging and Positron Emission Tomography, and pulmonary artery pressure waveform advanced analysis as well as other non or minimum invasive tools will be studied in animal models. Software, algorithm or dedicated products will be proposed for incorporation into the gas delivery system or clinical monitors for improving patient safety. We are expecting a clear benefit to emerging European-based technologies that make our companies more competitive and well-positioned in a worldwide business.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OPVANOX-ARDS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OPVANOX-ARDS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

COSMOS (2020)

The Conformation Of S-phase chroMOSomes

Read More  

COR1-TCELL (2019)

Analysis of the role for coronin 1-dependent cell density signalling in T-cell homeostasis

Read More  

GENESIS (2020)

unveilinG cEll-cell fusioN mEdiated by fuSexins In chordateS

Read More